Showing results (161-170 of 177) with videos related to

Sort By:
Pageof 18
Molecular Psychiatry|January 19, 2024
Connectome dysfunction in patients at clinical high risk for psychosis and modulation by oxytocinCathy Davies, Daniel Martins, Ottavia Dipasquale, et al.
Journal of Psychopharmacology (Oxford, England)|September 19, 2022
The association between N-methyl-d-aspartate receptor availability and glutamate levels: A multi-modal PET-MR brain imaging study in first-episode psychosis and healthy controlsKatherine Beck, Atheeshaan Arumuham, Stefan Brugger, et al.
The Lancet. Child & Adolescent Health|June 19, 2024
Comparative physiological effects of antipsychotic drugs in children and young people: a network meta-analysisMaria Rogdaki, Robert A McCutcheon, Enrico D'Ambrosio, et al.
Bjpsych Open|February 26, 2026
Treating Unmet Needs in Psychiatry (TUNE-UP): targeted service increases out-patient initiations of clozapineZmarak Ahmad Khan, Ioana Varvari, Valentina Mancini, et al.
JAMA Psychiatry|July 9, 2025
Incidence and Nature of Antidepressant Discontinuation Symptoms: A Systematic Review and Meta-AnalysisMichail Kalfas, Dimosthenis Tsapekos, Matthew Butler, et al.
Lancet (London, England)|October 24, 2025
The effects of antidepressants on cardiometabolic and other physiological parameters: a systematic review and network meta-analysisToby Pillinger, Atheeshaan Arumuham, Robert A McCutcheon, et al.
Schizophrenia Bulletin|December 10, 2024
Metformin for the Prevention of Antipsychotic-Induced Weight Gain: Guideline Development and Consensus ValidationAoife Carolan, Caroline Hynes-Ryan, Sri Mahavir Agarwal, et al.
The Lancet. Psychiatry|April 3, 2025
INTEGRATE: international guidelines for the algorithmic treatment of schizophreniaRobert A McCutcheon, Toby Pillinger, Ioana Varvari, et al.
Schizophrenia Bulletin|July 25, 2024
Do Cognitive Subtypes Exist in People at Clinical High Risk for Psychosis? Results From the EU-GEI StudyGeorge Gifford, Alessia Avila, Matthew J Kempton, et al.
Pageof 18